| Skolnick Mark HChief Scientific Officer, Director · 200 transactions | — | 2.60M†as of Nov 2009 | 323.0K | — | 440.4K |
| Raha Samraat S.President and CEO, Director · 13 transactions | — | 1.07M | 1.14M | 40.0K | — |
| Diaz Paul JPresident and CEO, Director · 36 transactions | — | 891.8Kas of Apr 2025 | 1.87M | — | 257.8K |
| Verratti MarkChief Operating Officer · 70 transactions | — | 629.6K | 765.6K | — | — |
| Donnelly Brian JChief Commerical Officer · 5 transactions | — | 573.4K | 629.3K | — | — |
| Capone Mark ChristopherPresident & C.E.O. · 110 transactions | — | 522.2Kas of Sep 2019 | 1.49M | 10.0K | 799.0K |
| Phanstiel S. LouiseDirector · 22 transactions | — | 374.8K† | 307.1K | 119.5K | 52.9K |
| Muzzey DaleChief Scientific Officer · 40 transactions | — | 326.3K | 368.5K | — | 2.1K |
| Fox Jennifer LynneChief Legal Officer · 5 transactions | — | 310.4K | 320.8K | — | — |
| Wheeler Benjamin RichardChief Financial Officer · 10 transactions | — | 298.5K | 271.2K | — | — |
| Riggsbee Richard BryanChief Financial Officer · 69 transactions | — | 291.8Kas of Jan 2024 | 673.4K | — | 145.0K |
| Solaiman ShereenChief People Officer · 10 transactions | — | 267.8K | 293.2K | — | — |
| Lanchbury Jerry SChief Scientific Officer · 267 transactions | — | 264.3Kas of Jan 2022 | 1.76M | — | 1.38M |
| Jampa RajChief Technology Officer · 1 transaction | — | 251.9K | 251.9K | — | — |
| Hobden Adrian NPres. Myriad Pharmaceuticals · 30 transactions | — | 234.1Kas of Jun 2009 | 263.9K | — | 168.0K |
| Dreismann HeinrichDirector · 6 transactions | — | 231.1K | 157.6K | — | 10.0K |
| Lambert NicoleChief Operating Officer · 46 transactions | — | 224.0Kas of Nov 2023 | 313.6K | — | 43.1K |
| Leffler Scott J.Chief Financial Officer · 5 transactions | — | 218.4Kas of Aug 2025 | 236.8K | — | — |
| Skovronsky DanielDirector · 7 transactions | — | 195.5K | 195.5K | — | — |
| Newcomer Lee NisleyDirector · 9 transactions | — | 191.8K | 198.0K | — | 6.2K |
| Haas Kevin RichardChief Technology Officer · 42 transactions | — | 188.4K | 216.6K | — | — |
| Hart Jayne B.Chief People Officer · 49 transactions | — | 172.6Kas of Mar 2023 | 348.3K | — | 214.9K |
| Kumar RashmiDirector · 9 transactions | — | 171.9K | 194.4K | — | 22.5K |
| Ford AlexanderChief Operating Officer · 33 transactions | — | 169.0Kas of Sep 2020 | 254.3K | — | 31.7K |
| Critchfield Gregory CPresident Myriad Genetic Labs · 24 transactions | — | 168.2Kas of Aug 2009 | 213.5K | — | 182.6K |
| Tobin BernardPresident Crescendo BioScience · 22 transactions | — | 160.6Kas of Sep 2019 | 239.6K | — | 11.7K |
| Bisaro PaulDirector · 6 transactions | — | 157.1K | 149.6K | 7.5K | — |
| Reitan Colleen FDirector · 9 transactions | — | 152.0K | 198.0K | — | 46.0K |
| Marsh Richard ME.V.P., General Counsel · 156 transactions | — | 149.7Kas of Sep 2018 | 1.10M | — | 857.4K |
| King Gary A.Exec. VP International Ops · 52 transactions | — | 148.4Kas of Sep 2019 | 468.6K | — | 274.1K |
| McDade Ralph LPresident Myriad RBM, Inc. · 22 transactions | — | 145.0Kas of Sep 2019 | 173.0K | 1.0K | 2.0K |
| Henderson John TDirector · 42 transactions | — | 144.5K†as of Dec 2019 | 230.8K | 13.3K | 170.0K |
| Ancona MargaretEVP, Strategy & Transformation · 21 transactions | — | 127.7K | 161.9K | — | 11.5K |
| Jackson BenjaminE.V.P., General Counsel · 12 transactions | — | 107.0Kas of Apr 2021 | 95.2K | — | — |
| Langer DennisDirector · 75 transactions | — | 106.8Kas of Jun 2022 | 351.8K | — | 245.0K |
| Davis Mark StevenDirector · 3 transactions | — | 106.7K | 106.7K | — | — |
| Parkinson PaulEVP Strategy and Innovation · 7 transactions | — | 87.4Kas of May 2021 | 32.4K | — | 11.8K |
| Dreismann HeinrichDirector · 17 transactions | — | 83.5Kas of Jun 2021 | 209.5K | — | 126.0K |
| Wong PamelaChief Legal Officer · 11 transactions | — | 65.0Kas of Mar 2024 | 77.1K | — | — |
| Best Lawrence CDirector · 9 transactions | — | 60.8Kas of Dec 2019 | 60.8K | — | 90.0K |
| Santa EricChief Growth Officer · 5 transactions | — | 56.7Kas of Apr 2022 | 59.7K | — | — |
| Gilbert Walter PHDDirector · 117 transactions | — | 54.1Kas of Dec 2019 | 370.8K | 5.9K | 358.4K |
| Wenstrup RichardChief Medical Officer · 5 transactions | — | 50.2Kas of Sep 2016 | 41.5K | — | — |
| Drosos VirginiaPresident Assurex Health · 1 transaction | — | 50.0Kas of Sep 2016 | 50.0K | — | — |
| Evans James SChief Financial Officer · 108 transactions | — | 48.1Kas of Sep 2014 | 482.1K | — | 466.4K |
| Munk NatalieChief Accounting Officer · 26 transactions | — | 45.2K | 30.8K | — | — |
| Laslie W WayneChief Operating Officer, MPI · 11 transactions | — | 44.3Kas of May 2009 | 89.3K | — | 56.1K |
| Sanders Walter LloydPresident Myriad Oncology · 4 transactions | — | 36.2Kas of Sep 2018 | — | — | — |
| Spiegelman Daniel KDirector · 12 transactions | — | 32.9Kas of Jun 2024 | 81.7K | — | 32.9K |
| Harrison Robert GardnerChief Information Officer · 64 transactions | — | 25.8Kas of Sep 2014 | 202.5K | — | 184.2K |
| Moyes Jay MChief Financial Officer · 285 transactions | — | 25.7K†as of Oct 2007 | 167.0K | — | 158.1K |
| Rogers Ronald S.Exec VP Corp Communications · 5 transactions | — | 16.0Kas of Sep 2014 | 28.5K | — | 12.5K |
| Hayes Arthur Hull JrDirector · 11 transactions | — | 15.0Kas of May 2007 | 45.0K | — | 55.0K |
| Wilson Linda SDirector · 43 transactions | — | 11.5Kas of Jan 2010 | 83.0K | — | 84.0K |
| Meldrum Peter DPresident & C.E.O., Director · 231 transactions | — | 10.4Kas of May 2015 | 1.10M | — | 1.15M |
| Hockett William A IIIV. P. of Corp Communications · 98 transactions | — | 9.0Kas of Sep 2008 | 155.2K | — | 154.1K |
| Simon S GeorgeV.P. Business Development · 10 transactions | — | 7.3Kas of Jan 2007 | 25.0K | — | 25.0K |
| Belle Gerald P.Director · 1 transaction | — | 1.2Kas of May 2009 | — | 1.0K | — |